Maternal exposure to GLP-1 receptor agonists during pregnancy was not associated with a statistically significant increase in the overall risk of congenital disabilities, with an odds ratio (OR) of 1.11 and a 95% confidence interval (CI) of 0.82-1.51
Batch-specific Certificate of Analysis available on request
Son also recommends products containing polydeoxyribonucleotide (PDRN), which are "barrier repairing and also contribute to cellular regeneration." In other words, they help repair the skin barrier while supporting new cell growth
Saying that, l-carnitine supplementation certainly has a place alongside other prescription medication to help slow cognitive decline
Healthcare providers might increase the dose as needed, but its vital to consult with them before making any change yourself
Now, researchers are exploring new iterations, including oral versions and multi-pathway therapies